Medical
Information
Full Information
about Your Health
 
Asthma and Other
Allergic Diseases
Behavior and Mental
Health Issues
Birth Defects and Other
Congenital Conditions
Breast and Bottle Feeding
Child Abuse
Child Care
Childhood Illnesses
Dental Health
Diabetes and Other
Endocrine Conditions
Ear Infections
Environmental Health
Especially for Teens
Eye Care and Conditions
Family Issues
Growth and Development
Infant Care
Infectious Disease
and Immunization
Learning Disabilities
Premature Infants
Prenatal and
Newborn Care
Sexuality
Skin Care
Sleep Issues
Youth Violence
Blood Disorders
Complementary and
Alternative Medicine
Fitness and Nutrition
Medical Tests
and Medications
Pain Management
Physical Medicine
and Rehabilitation
Plastic Surgery,
Cosmetic and
Reconstructive Procedures
Preventive Medicine
Online Pharmacy
generic viagra online

EFFECT OF POSTPARTUM IRON SUPPLEMENTATION ON RED CELL AND IRON PARAMETERS IN NON-ANAEMIC IRON-DEFICIENT WOMEN: A RANDOMISED PLACEBO-CONTROLLED STUDY

Krafft A, Perewusnyk G, Hanseler E, Quack K, Huch R, Breymann C.

BJOG. 2005 Apr;112(4):445-50.

Objective

To investigate the effect of oral iron on postpartum red cell and iron parameters in non-anaemic women with iron deficiency.

Design

Randomised study of supplementation with oral iron sulphate 80 mg daily or placebo for 12 weeks starting 24-48 hours after delivery, with visits antepartum and 1, 4, 6 and 12 weeks postpartum.

Setting

Swiss university hospital obstetric unit.

Participants

Fifty-two women with antenatal iron deficiency (serum ferritin <15 microg/L) and no antenatal or postnatal anaemia (haemoglobin >11 g/dL up to 48 hours before delivery, and >10 g/dL postpartum), divided into two groups comparable in antenatal iron status.

Methods

Supplementation was started 24-48 hours after delivery (visit 1:V1). Additional tablets were issued one week after V1 (V2), four weeks after V1 (V3) and six weeks after V1 (V4). The last visit took place 12 weeks after visit 1 and 6 weeks after visit 4 (V5). Patients were required to return blisters and boxes whether they were used and unused at each visit and compliance was assessed by counting the tablets. Blood samples for haematology and iron status testing were taken before delivery and at each visit.

Main outcome measures

Iron status (serum ferritin, hypochromic red cells, iron, transferrin saturation, soluble transferrin receptor concentration); erythropoiesis (standard parameters, including reticulocyte indices); and inflammatory response (serum neopterin, C-reactive protein, white cell count) in five-datapoint profiles.

Results

Increased ferritin (P= 0.0004) and transferrin saturation (P= 0.03), decreased soluble transferrin receptors (P= 0.02); increased haemoglobin (P= 0.02) and decreased hypochromic red cells (P= 0.04) compared with placebo at 12 weeks, with no differences in other red cell or reticulocyte parameters. There was a positive correlation between C-reactive protein and postpartum ferritin. No correlation was observed in the puerperium between C-reactive protein and hypochromic red cells or soluble transferrin receptors.

Conclusions

Haemoglobin levels and iron stores in women with term gestational iron deficiency benefit significantly from iron supplementation compared with placebo, even in an industrialised population.


Home Page | For Medical Specialists | For Patients | Medications | Price List | Contact Details
© 2008 http://medinforms.com. All Rights Reserved